Fundraising FoxOrna Therapeutics Holdings, LLC
Cambridge, US · Founded 2020 · 2 known investors
Find your way into Orna Therapeutics Holdings, LLC
Sign up to see every warm intro you have to Orna Therapeutics Holdings, LLC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orna Therapeutics Holdings, LLC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Circular RNA-based cell engineering
Founders & leadership
Orna Therapeutics Holdings, LLC was founded in 2020 by Daniel Anderson and Thomas M. Barnes.
DA
Daniel AndersonCo-founderDaniel Anderson is Director at Orna Therapeutics Holdings, which develops circular RNA-based cell engineering technology. He has held operations and team leadership roles of increasing scope.
TM
Thomas M. BarnesCo-founder
RM
Robert MarbyExecutive
WS
William ShenExecutive
NK
Nishla KeiserExecutive
Board
BG
SA
Sakae AsanumaBoard director
MJ
Morana Jovan-EmbiricosBoard director
AG
TE
Thomas EbelingBoard director
FM
Francesco MarincolaBoard director
Investors · 2
Astellas Venture Management LLClisted by Astellas Venture Management LLCSouth San Francisco · $200K – $5M
How we know: Astellas Venture Management LLC's portfolio page · Not right? Tell us
MPM BioImpactinferredBoston · $1M – $15Mvia Ansbert Gadicke · board
How we know: board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$120.6M disclosed across 1 round · 2022
▶$120.6MraisedAug 2022 · 17 investors · BiotechnologyRule 506(b)
▶$120.6MraisedAug 2022 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian GoodmanDirector
- Sakae AsanumaDirector
- Daniel AndersonDirector
- Robert MarbyExecutive Officer
- John McCabeExecutive Officer
- William ShenExecutive Officer
- Morana Jovan-EmbiricosDirector
- Nishla KeiserExecutive Officer
- Thomas EbelingDirector
- Francesco MarincolaDirector
- Ansbert GadickeDirector
- Thomas M. BarnesExecutive Officer, Director
- Offering amount
- $300M
- Amount sold
- $120.6M
- First sale
- Aug 2022
- Incorporated
- Limited Liability Company, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Orna Therapeutics Holdings, LLC went on to found or lead other companies.
Frequently asked questions
- What does Orna Therapeutics Holdings, LLC do?
- Circular RNA-based cell engineering
- Who founded Orna Therapeutics Holdings, LLC?
- Orna Therapeutics Holdings, LLC was founded by Daniel Anderson, Thomas M. Barnes in 2020.
- Who are Orna Therapeutics Holdings, LLC's investors?
- Orna Therapeutics Holdings, LLC's investors include Astellas Venture Management LLC, MPM BioImpact.
- How much funding has Orna Therapeutics Holdings, LLC raised?
- Orna Therapeutics Holdings, LLC has disclosed $120.6M raised across 1 round.
- Where is Orna Therapeutics Holdings, LLC headquartered?
- Orna Therapeutics Holdings, LLC is headquartered in Cambridge, US.